Lettmann Jason

CHIEF EXECUTIVE OFFICER at ALXO; Director at Ra Pharmaceuticals, Inc.

Sold, on record
$13.6M
Dollars the filings state
Form 4 sales
7
Latest Aug 17, 2026
Form 144 notices
0
Proposed sales
Companies
2
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
2
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Sales by company

Shares sold, every Form 4 sale on record.

Timeline

  1. 1 Form 4 sale Ra Pharmaceuticals, Inc.Plan not stated
    Oct 31, 2016 2016

    Sold 340 shares at $13.00 ($4k)

    Lettmann Jason, Director

    Sold 0.4% of holdings ($1M position)79,821 shares leftFirst sale on recordFiling

  2. 2 Form 4 sale ALXOUnusual
    Dec 10, 2021 +1866 days

    Sold 145,637 shares at $32.26 ($4.7M)

    Lettmann Jason, Director, 10% owner

    Sold 33.3% of holdings ($14.1M position)291,758 shares leftFirst sale on recordFiling

  3. 3 Form 4 sale ALXOUnusual
    Dec 13, 2021 +3 days

    Sold 325,377 shares at $27.36 ($8.9M)

    Name not stated, Director, 10% owner

    Sold 53.2% of holdings ($16.7M position)285,956 shares leftFiling

  4. 4 Form 4 sale ALXONo plan
    Feb 19, 2025 +1164 days

    Sold 2,159 shares at $1.15 ($2k)

    Lettmann Jason, CHIEF EXECUTIVE OFFICER

    No 10b5-1 planSold 1.3% of holdings ($198k position)170,270 shares leftFirst sale on recordFiling

  5. 5 Form 4 sale ALXONo plan
    Aug 15, 2025 +177 days

    Sold 2,382 shares at $0.64 ($2k)

    Lettmann Jason, CHIEF EXECUTIVE OFFICER

    No 10b5-1 planSold 1.1% of holdings ($138k position)212,888 shares leftFiling

  6. 6 Form 4 sale ALXONo plan
    Mar 19, 2026 +216 days

    Sold 12,311 shares at $2.17 ($27k)

    Lettmann Jason, CHIEF EXECUTIVE OFFICER

    No 10b5-1 planSold 4% of holdings ($664k position)293,609 shares leftFiling

  7. 7 Form 4 sale ALXONo plan
    Aug 17, 2026 +151 days

    Sold 2,230 shares at $1.93 ($4k)

    Lettmann Jason, CHIEF EXECUTIVE OFFICER

    No 10b5-1 planSold 0.8% of holdings ($572k position)294,379 shares left0.9x usual sizeFiling

Every transaction

Loading transactions…

Sales and notices (7)

Form 144 notices and Form 4 sales by Lettmann Jason
Source
Aug 17, 2026Aug 18, 2026ALXOCHIEF EXECUTIVE OFFICERForm 4 sale2,230$4k0.8%No planSEC
Mar 19, 2026Mar 23, 2026ALXOCHIEF EXECUTIVE OFFICERForm 4 sale12,311$27k4.0%No planSEC
Aug 15, 2025Aug 19, 2025ALXOCHIEF EXECUTIVE OFFICERForm 4 sale2,382$2k1.1%No planSEC
Feb 19, 2025Feb 21, 2025ALXOCHIEF EXECUTIVE OFFICERForm 4 sale2,159$2k1.3%No planSEC
Dec 13, 2021Dec 15, 2021ALXODirector, 10% ownerForm 4 sale325,377$8.9M53.2%UnusualSEC
Dec 10, 2021Dec 10, 2021ALXODirector, 10% ownerForm 4 sale145,637$4.7M33.3%UnusualSEC
Oct 31, 2016Oct 31, 2016Ra Pharmaceuticals, Inc.DirectorForm 4 sale340$4k0.4%Plan not statedSEC